Local Institution - 2102

New York, New York 10065

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumors, Primary CNS Tumors

Studies at this site

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — Recruiting now
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — Recruiting now